Diabetes Supplements Market Outlook 2031

  • The global diabetes supplements market was valued at US$ 8.4 Bn in 2020
  • It is estimated to expand at a CAGR of 4.2% from 2021 to 2031
  • The global diabetes supplements market is expected to reach the value of US$ 13.4 Bn by the end of 2031

Analysts’ Viewpoint on Diabetes Supplements Market Scenario

The global diabetes supplements market is driven by the rising incidences of chronic diseases such as diabetes, causing millions of deaths every year. Geriatric population is more likely to suffer from the chronic conditions. Asia Pacific is a major consumer of diabetes supplements due to rising number of elderly population in region. These dietary supplements are used to lower blood sugar levels. Diabetes is considered to be a major cause of death, and hence, there is an increasing need to improve treatment for diabetes across the globe. Changing lifestyle, obesity, and excessive cholesterol levels are some of the major factors responsible for prevalence of diabetes in people, thereby propelling the demand for diabetes supplements, thus enhancing the diabetes supplements market growth during the forecast period.

Increase in Awareness about Health and Fitness to Boost Global Market

The global diabetes supplements market is majorly driven by the rising geriatric population across the globe. The increase in the number of chronic disorders across the globe is also a significant factor responsible for rising demand for diabetes supplements. Geriatric population is more likely to suffer from chronic diseases such as diabetes. They also have high risks of other health conditions. Thus, it is a real challenge for physicians to provide them proper supplements, which do not cause any side-effects.

Increasing health & fitness awareness among people after the threatening pandemic is expected to drive the global diabetes supplements market in the upcoming years. There is a growing demand for treatment and prevention of diabetes across the globe. This factor is likely to drive the global diabetes supplements market in the upcoming years.

Request a sample to get extensive insights into the Diabetes Supplements Market

Lucrative Opportunities for Market Players in Diabetes Supplements Market

Companies in the global diabetes supplements market are expected to join forces with researchers to introduce various products in order to cater to the demand from consumers at the global level. Growing government expenditure on healthcare, along with rising awareness about chronic diseases is fueling the expansion of the global diabetes supplements market. Manufacturers are making use of pharmaceutical innovations to develop efficient diabetes supplements. These factors are contributing to the rapid expansion of the market, thereby creating potential benefits for the market players. The rise in adoption of dietary supplements among geriatric people is fueling the market growth.

Diabetes supplements can include ingredients such as vitamins, minerals, herbs, amino acids, metabolites, etc. These supplements are widely used in order to lower blood glucose and blood pressure, improve cholesterol, and for other complications in diabetic patients.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Growth of Distribution Channels in Diabetes Supplements Market

The increasing sales of diabetes supplements during the coronavirus pandemic is helping product manufacturers to compete with top market players. Factors such as expanding offline distribution channels including hospital pharmacies and retail pharmacies help manufacturers to showcase their products and leverage revenue opportunities. Rise in the number of people affected with Type 1 and Type 2 diabetic is attributable to the market growth. Growing health awareness is also contributing to the market growth. Moreover, development of eCommerce industry and rapidly expanding online distribution channels such as online pharmacies are boosting the sales of diabetes supplements across the globe. In addition, manufacturers are increasing the availability of various dosage forms such as tablets, powder, solution, etc.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Diabetes Supplements Market

Value-grab Opportunities for Market Players in North America

North America offers lucrative growth opportunities in the diabetes supplements market due to rising geriatric population, advancement in pharmaceutical industry, and increasing number of patients suffering from diabetes. Rising investments in R&D activities in diabetes supplements is driving the growth of the market. Market contributors from North America are focusing on adopting various strategies to strengthen their market presence.

Growing number of people suffering from diabetes, increasing healthcare expenditure, rising health awareness among people, and availability of key market contributors are some of the major factors propelling the expansion of the Asia Pacific diabetes supplement market. Market players in the Asia Pacific diabetes supplements market are focusing on various strategies to pave their ways in the global market.

Diabetes Supplements Market: Overview

  • Diabetes is a disease that occurs when your blood glucose, also called blood sugar, is too high. Over time, having too much glucose in the blood can cause health problems.
  • About 9.4% of the people in the U.S. have diabetes, but about one in four people who have diabetes do not know it
  • Diabetes has no cure; however, people with diabetes can take steps to manage their condition and stay healthy. Taking insulin or other diabetes medicines is often part of treating diabetes, along with healthy food choices and physical activity.
  • Increase in geriatric population across the globe fuels the growth of the global diabetes supplements market, as elderly people are more prone to chronic diseases such as diabetes
  • Elderly people with diabetes have a higher risk of conditions such as cognitive impairment & dementia, frailty, traumatic falls & fractures, urinary incontinence, side effects of polypharmacy, and disability, which presents a real challenge for physicians
  • According to data published by the World Health Organization (WHO), the population of elderly people (60+) was 1 billion and the number is expected to increase to 1.4 billion by 2030 and 2.1 billion by 2050
  • According to the United Nations Economic and Social Commission for Asia and the Pacific, around 60% of the world’s geriatric population lives in Asia Pacific
  • Moreover, one third of the U.S. population 65+ years old has diabetes, and it is one of the prominent causes of mortality and morbidity among this population. Hence, demand for diabetes prevention and treatment products is expected to increase, which in turn is likely to drive the global diabetes supplements market.

Diabetes Supplements Diabetes Supplements Market: Segmentation

  • In terms of type, the global diabetes supplements market has been classified into vitamins, minerals, proteins, antioxidant & fatty acids, dietary fibers, and others
  • Based on disease type, the global diabetes supplements market has been bifurcated into type 1 and type 2
  • In terms of dosage form, the global diabetes supplements market has been categorized into tablets, solution, powder, and others
  • Based on distribution channel, the global diabetes supplements market has been divided into hospital pharmacies, retail pharmacies, and online pharmacies
  • Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The diabetes supplements market report provides current and expected revenue (US$ Mn) for each of these segments from 2021 to 2031, considering 2020 as the base year. The compound annual growth rate (percentage CAGR) has been provided for each segment and market from 2021 to 2031 along with market size estimations.

Regional Overview: Diabetes Supplements Market

  • In terms of region, the global diabetes supplements market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa
  • Recent product launches in the U.S., high adoption of dietary supplement among adults & the geriatric population, and increase in awareness about health lifestyle among diabetes patients are factors projected to drive the market in North America
  • In May 2015, Glucose Health, Inc. launched Glucose Health Natural Blood Sugar Maintenance, an innovative new dietary supplement for patients with type 2 diabetes

Diabetes Supplements Market: Major Players

  • The diabetes supplements market report concludes with the company profiles section, which includes key information about major players in the global diabetes supplements market
  • Leading players analyzed in the report include
    • Abbott (Abbott Healthcare Pvt. Ltd.)
    • Aksuvital Natural Products Co.
    • Arkopharma
    • Bionova
    • Caelus Health
    • CuraLife Global
    • Glucose Health, Inc.
    • Hexagon Nutrition Pvt. Ltd.
    • La Grande P Ltd. (La Nutraceuticals)
    • Lysulin, Inc.
    • Nature's Sunshine Products, Inc.
    • Nestlé Health Science
    • Nutricia
    • Olive Healthcare
  • Each of these players has been profiled in the diabetes supplements market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments

Diabetes Supplements Market Snapshot

Attribute

Detail

Market Size Value in 2020

US$ 8.4 Bn

Market Forecast Value in 2031

US$ 13.4 Bn

Growth Rate (CAGR)

4.2%

Forecast Period

2021–2031

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market player - competition matrix (by tier and size of companies)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Disease Type
    • Type 1
    • Type 2
  • Dosage Form
    • Tablets
    • Solution
    • Powder
    • Others
  • Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Type
    • Vitamins
    • Minerals
    • Proteins
    • Antioxidant & Fatty Acids
    • Dietary Fibers
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Abbott (Abbott Healthcare Pvt. Ltd.)
  • Aksuvital Natural Products Co.
  • Arkopharma
  • Bionova
  • Caelus Health
  • CuraLife Global
  • Glucose Health, Inc.
  • Hexagon Nutrition Pvt. Ltd.
  • La Grande P. Ltd. (La Nutraceuticals)
  • Lysulin, Inc.
  • Nature's Sunshine Products, Inc.
  • Nestlé Health Science
  • Nutricia
  • Olive Healthcare
  • Other prominent players

Customization Scope

Available upon request

Pricing

Available upon request

Diabetes Supplements Market – Segmentation

TMR’s study on the global diabetes supplements market includes information divided into five segments: disease type, dosage form, distribution channel, type, and region. Changing industry trends and other market dynamics associated with these segments of the global diabetes supplements market are discussed in detail.

Disease Type
  • Type 1
  • Type 2
Dosage Form
  • Tablets
  • Solution
  • Powder
  • Others
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Type
  • Vitamins
  • Minerals
  • Proteins
  • Antioxidant & Fatty Acids
  • Dietary Fibers
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

Diabetes supplements market is expected to reach the value of US$ 13.4 Bn by the end of 2031

Diabetes supplements market is estimated to expand at a CAGR of 4.2% from 2021 to 2031

Diabetes supplements market is driven by rising geriatric population and increase in the number of chronic disorders across the globe

North America accounted for a major share of the global diabetes supplements market

Key players operating in the global diabetes supplements market include Abbott (Abbott Healthcare Pvt. Ltd.), Aksuvital Natural Products Co., Arkopharma, Bionova, Caelus Health

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Diabetes Supplements Market

4. Market Overview

    4.1. Introduction

        4.1.1. Market Introduction

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Diabetes Supplements Market Analysis and Forecast, 2017–2031

5. Key Insights

    5.1. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)

    5.2. Key Industry Events (products launch, approval, merger & acquisition, etc.)

    5.3. Epidemiology of Diabetes, by Region/Country

6. Global Diabetes Supplements Market Analysis and Forecast, by Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Type, 2017–2031

        6.3.1. Vitamins

        6.3.2. Minerals

        6.3.3. Proteins

        6.3.4. Antioxidant & Fatty Acids

        6.3.5. Dietary Fibers

        6.3.6. Others

    6.4. Market Attractiveness Analysis, by Type

7. Global Diabetes Supplements Market Analysis and Forecast, by Disease Type

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Disease Type, 2017–2031

        7.3.1. Type 1

        7.3.2. Type 2

    7.4. Market Attractiveness Analysis, by Disease Type

8. Global Diabetes Supplements Market Analysis and Forecast, by Dosage Form

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Dosage Form, 2017–2031

        8.3.1. Tablets

        8.3.2. Solution

        8.3.3. Powder

        8.3.4. Others

    8.4. Market Attractiveness Analysis, by Dosage Form

9. Global Diabetes Supplements Market Analysis and Forecast, by Distribution Channel

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Market Value Forecast, by Distribution Channel, 2017–2031

        9.3.1. Hospital Pharmacies

        9.3.2. Retail Pharmacies

        9.3.3. Online Pharmacies

    9.4. Market Attractiveness Analysis, by Distribution Channel

10. Global Diabetes Supplements Market Analysis and Forecast, by Region

    10.1. Key Findings

    10.2. Market Value Forecast, by Region

        10.2.1. North America

        10.2.2. Europe

        10.2.3. Asia Pacific

        10.2.4. Latin America

        10.2.5. Middle East & Africa

    10.3. Market Attractiveness Analysis, by Region

11. North America Diabetes Supplements Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Type, 2017–2031

        11.2.1. Vitamins

        11.2.2. Minerals

        11.2.3. Proteins

        11.2.4. Antioxidant & Fatty Acids

        11.2.5. Dietary Fibers

        11.2.6. Others

    11.3. Market Value Forecast, by Disease Type, 2017–2031

        11.3.1. Type 1

        11.3.2. Type 2

    11.4. Market Value Forecast, by Dosage Form, 2017–2031

        11.4.1. Tablets

        11.4.2. Solution

        11.4.3. Powder

        11.4.4. Others

    11.5. Market Value Forecast, by Distribution Channel, 2017–2031

        11.5.1. Hospital Pharmacies

        11.5.2. Retail Pharmacies

        11.5.3. Online Pharmacies

    11.6. Market Value Forecast, by Country, 2017–2031

        11.6.1. U.S.

        11.6.2. Canada

    11.7. Market Attractiveness Analysis

        11.7.1. By Type

        11.7.2. By Disease Type

        11.7.3. By Dosage Form

        11.7.4. By Distribution Channel

        11.7.5. By Country

12. Europe Diabetes Supplements Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Type, 2017–2031

        12.2.1. Vitamins

        12.2.2. Minerals

        12.2.3. Proteins

        12.2.4. Antioxidant & Fatty Acids

        12.2.5. Dietary Fibers

        12.2.6. Others

    12.3. Market Value Forecast, by Disease Type, 2017–2031

        12.3.1. Type 1

        12.3.2. Type 2

    12.4. Market Value Forecast, by Dosage Form, 2017–2031

        12.4.1. Tablets

        12.4.2. Solution

        12.4.3. Powder

        12.4.4. Others

    12.5. Market Value Forecast, by Distribution Channel, 2017–2031

        12.5.1. Hospital Pharmacies

        12.5.2. Retail Pharmacies

        12.5.3. Online Pharmacies

    12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Market Attractiveness Analysis

        12.7.1. By Type

        12.7.2. By Disease Type

        12.7.3. By Dosage Form

        12.7.4. By Distribution Channel

        12.7.5. By Country/Sub-region

13. Asia Pacific Diabetes Supplements Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Type, 2017–2031

        13.2.1. Vitamins

        13.2.2. Minerals

        13.2.3. Proteins

        13.2.4. Antioxidant & Fatty Acids

        13.2.5. Dietary Fibers

        13.2.6. Others

    13.3. Market Value Forecast, by Disease Type, 2017–2031

        13.3.1. Type 1

        13.3.2. Type 2

    13.4. Market Value Forecast, by Dosage Form, 2017–2031

        13.4.1. Tablets

        13.4.2. Solution

        13.4.3. Powder

        13.4.4. Others

    13.5. Market Value Forecast, by Distribution Channel, 2017–2031

        13.5.1. Hospital Pharmacies

        13.5.2. Retail Pharmacies

        13.5.3. Online Pharmacies

    13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.6.1. China

        13.6.2. Japan

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Market Attractiveness Analysis

        13.7.1. By Type

        13.7.2. By Disease Type

        13.7.3. By Dosage Form

        13.7.4. By Distribution Channel

        13.7.5. By Country/Sub-region

14. Latin America Diabetes Supplements Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Type, 2017–2031

        14.2.1. Vitamins

        14.2.2. Minerals

        14.2.3. Proteins

        14.2.4. Antioxidant & Fatty Acids

        14.2.5. Dietary Fibers

        14.2.6. Others

    14.3. Market Value Forecast, by Disease Type, 2017–2031

        14.3.1. Type 1

        14.3.2. Type 2

    14.4. Market Value Forecast, by Dosage Form, 2017–2031

        14.4.1. Tablets

        14.4.2. Solution

        14.4.3. Powder

        14.4.4. Others

    14.5. Market Value Forecast, by Distribution Channel, 2017–2031

        14.5.1. Hospital Pharmacies

        14.5.2. Retail Pharmacies

        14.5.3. Online Pharmacies

    14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Market Attractiveness Analysis

        14.7.1. By Type

        14.7.2. By Disease Type

        14.7.3. By Dosage Form

        14.7.4. By Distribution Channel

        14.7.5. By Country/Sub-region

15. Middle East & Africa Diabetes Supplements Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Market Value Forecast, by Type, 2017–2031

        15.2.1. Vitamins

        15.2.2. Minerals

        15.2.3. Proteins

        15.2.4. Antioxidant & Fatty Acids

        15.2.5. Dietary Fibers

        15.2.6. Others

    15.3. Market Value Forecast, by Disease Type, 2017–2031

        15.3.1. Type 1

        15.3.2. Type 2

    15.4. Market Value Forecast, by Dosage Form, 2017–2031

        15.4.1. Tablets

        15.4.2. Solution

        15.4.3. Powder

        15.4.4. Others

    15.5. Market Value Forecast, by Distribution Channel, 2017–2031

        15.5.1. Hospital Pharmacies

        15.5.2. Retail Pharmacies

        15.5.3. Online Pharmacies

    15.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of Middle East & Africa

    15.7. Market Attractiveness Analysis

        15.7.1. By Type

        15.7.2. By Disease Type

        15.7.3. By Dosage Form

        15.7.4. By Distribution Channel

        15.7.5. By Country/Sub-region

16. Competition Landscape

    16.1. Market Player – Competition Matrix (by Tier and Size of companies)

    16.2. Market Share Analysis/Ranking by Company (2020)

    16.3. Company Profiles

        16.3.1. Abbott (Abbott Healthcare Pvt. Ltd.)

            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.1.2. Company Financials

            16.3.1.3. Growth Strategies

            16.3.1.4. SWOT Analysis

        16.3.2. Aksuvital Natural Products Co.

            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.2.2. Company Financials

            16.3.2.3. Growth Strategies

            16.3.2.4. SWOT Analysis

        16.3.3. Arkopharma

            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.3.2. Company Financials

            16.3.3.3. Growth Strategies

            16.3.3.4. SWOT Analysis

        16.3.4. Bionova

            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.4.2. Company Financials

            16.3.4.3. Growth Strategies

            16.3.4.4. SWOT Analysis

        16.3.5. Caelus Health

            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.5.2. Company Financials

            16.3.5.3. Growth Strategies

            16.3.5.4. SWOT Analysis

        16.3.6. CuraLife Commerce SIA

            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.6.2. Company Financials

            16.3.6.3. Growth Strategies

            16.3.6.4. SWOT Analysis

        16.3.7. Glucose Health, Inc.

            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.7.2. Company Financials

            16.3.7.3. Growth Strategies

            16.3.7.4. SWOT Analysis

        16.3.8. Hexagon Nutrition Pvt. Ltd.

            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.8.2. Company Financials

            16.3.8.3. Growth Strategies

            16.3.8.4. SWOT Analysis

        16.3.9. La Grande P Ltd. (La Nutraceuticals)

            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.9.2. Company Financials

            16.3.9.3. Growth Strategies

            16.3.9.4. SWOT Analysis

        16.3.10. Lysulin, Inc.

            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.10.2. Company Financials

            16.3.10.3. Growth Strategies

            16.3.10.4. SWOT Analysis

        16.3.11. Nature's Sunshine Products, Inc.

            16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.11.2. Company Financials

            16.3.11.3. Growth Strategies

            16.3.11.4. SWOT Analysis

        16.3.12. Nestlé Health Science

            16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.12.2. Company Financials

            16.3.12.3. Growth Strategies

            16.3.12.4. SWOT Analysis

        16.3.13. Nutricia

            16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.13.2. Company Financials

            16.3.13.3. Growth Strategies

            16.3.13.4. SWOT Analysis

        16.3.14. Olive Healthcare

            16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.14.2. Company Financials

            16.3.14.3. Growth Strategies

            16.3.14.4. SWOT Analysis

        16.3.15. Other Prominent Players

            16.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.15.2. Company Financials

            16.3.15.3. Growth Strategies

            16.3.15.4. SWOT Analysis

List of Tables

Table 01: Global Diabetes Supplements Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 02: Global Diabetes Supplements Market Value (US$ Mn), Forecast, 2017–2031

Table 03: Global Diabetes Supplements Market Value (US$ Mn) Forecast, by Dosage Form, 2017‒2031

Table 04: Global Diabetes Supplements Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

Table 05: Global Diabetes Supplements Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 06: North America Diabetes Supplement Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 07: North America Diabetes Supplements Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 08: North America Diabetes Supplements Market Value (US$ Mn), Forecast, 2017–2031

Table 09: North America Diabetes Supplements Market Value (US$ Mn) Forecast, by Dosage Form, 2017‒2031

Table 10: North America Diabetes Supplements Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

Table 11: Europe Diabetes Supplement Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 12: Europe Diabetes Supplements Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 13: Europe Diabetes Supplements Market Value (US$ Mn), Forecast, 2017–2031

Table 14: Europe Diabetes Supplements Market Value (US$ Mn) Forecast, by Dosage Form, 2017‒2031

Table 15: Europe Diabetes Supplements Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

Table 16: Asia Pacific Diabetes Supplement Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 17: Asia Pacific Diabetes Supplements Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 18: Asia Pacific Diabetes Supplements Market Value (US$ Mn), Forecast, 2017–2031

Table 19: Asia Pacific Diabetes Supplements Market Value (US$ Mn) Forecast, by Dosage Form, 2017‒2031

Table 20: Asia Pacific Diabetes Supplements Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

Table 21: Latin America Diabetes Supplement Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 22: Latin America Diabetes Supplements Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 23: Latin America Diabetes Supplements Market Value (US$ Mn), Forecast, 2017–2031

Table 24: Latin America Diabetes Supplements Market Value (US$ Mn) Forecast, by Dosage Form, 2017‒2031

Table 25: Latin America Diabetes Supplements Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

Table 26: Middle East & Africa Diabetes Supplement Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 27: Middle East & Africa Diabetes Supplements Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 28: Middle East & Africa Diabetes Supplements Market Value (US$ Mn), Forecast, 2017–2031

Table 29: Middle East & Africa Diabetes Supplements Market Value (US$ Mn) Forecast, by Dosage Form, 2017‒2031

Table 30: Middle East & Africa Diabetes Supplements Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031

List of Figures

Figure 01: Global Diabetes Supplements Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Diabetes Supplements Market Value Share, by Type, 2020

Figure 03: Global Diabetes Supplements Market Value Share, by Disease Type, 2020

Figure 04: Global Diabetes Supplements Market Value Share, by Dosage Form, 2020

Figure 05: Global Diabetes Supplements Market Value Share, by Distribution Channel, 2020

Figure 06: Global Diabetes Supplements Market Value Share, by Region, 2020

Figure 07: Global Diabetes Supplements Market Value Share Analysis, by Type, 2020 and 2031

Figure 08: Global Diabetes Supplements Market Attractiveness Analysis, by Type, 2021–2031

Figure 09: Global Diabetes Supplements Market Revenue (US$ Mn), by Vitamins, 2017–2031

Figure 10: Global Diabetes Supplements Market Revenue (US$ Mn), by Minerals, 2017–2031

Figure 11: Global Diabetes Supplements Market Revenue (US$ Mn), by Proteins, 2017–2031

Figure 12: Global Diabetes Supplements Market Revenue (US$ Mn), by Antioxidant & Fatty Acids, 2017–2031

Figure 13: Global Diabetes Supplements Market Revenue (US$ Mn), by Dietary Fibers, 2017–2031

Figure 14: Global Diabetes Supplements Market Revenue (US$ Mn), by Others, 2017–2031

Figure 15: Global Diabetes Supplements Market, by Disease Type, 2020 and 2031

Figure 16: Global Diabetes Supplements Market, by Disease Type, 2021–2031

Figure 17: Global Diabetes Supplements Market (US$ Mn), by Type 1, 2017–2031

Figure 18: Global Diabetes Supplements Market (US$ Mn), by Type 2, 2017–2031

Figure 19: Global Diabetes Supplements Market, by Dosage Form, 2020 and 2031

Figure 20: Global Diabetes Supplements Market, by Dosage Form, 2021–2031

Figure 21: Global Diabetes Supplements Market (US$ Mn), by Tablets, 2017–2031

Figure 22: Global Diabetes Supplements Market (US$ Mn), by Solution, 2017–2031

Figure 23: Global Diabetes Supplements Market (US$ Mn), by Anti-Powder, 2017–2031

Figure 24: Global Diabetes Supplements Market (US$ Mn), by Others, 2017–2031

Figure 25: Global Diabetes Supplements Market, by Distribution Channel, 2020 and 2031

Figure 26: Global Diabetes Supplements Market, by Distribution Channel, 2021–2031

Figure 27: Global Diabetes Supplements Market (US$ Mn), by Hospital Pharmacies, 2017–2031

Figure 28: Global Diabetes Supplements Market (US$ Mn), by Retail Pharmacies, 2017–2031

Figure 29: Global Diabetes Supplements Market (US$ Mn), by Online Pharmacies, 2017–2031

Figure 30: Global Diabetes Supplement Market Value Share Analysis, by Region, 2020 and 2031

Figure 31: Global Diabetes Supplement Market Attractiveness Analysis, by Region, 2021–2031

Figure 32: North America Diabetes Supplements Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 33: North America Diabetes Supplement Market Value Share Analysis, by Country, 2020 and 2031

Figure 34: North America Diabetes Supplement Market Attractiveness Analysis, by Country, 2021–2031 

Figure 35: North America Diabetes Supplements Market Value Share Analysis, by Type, 2020 and 2031

Figure 36: North America Diabetes Supplements Market Attractiveness Analysis, by Type, 2021–2031

Figure 37: North America Diabetes Supplements Market, by Disease Type, 2020 and 2031

Figure 38: North America Diabetes Supplements Market, by Disease Type, 2021–2031

Figure 39: North America Diabetes Supplements Market, by Dosage Form, 2020 and 2031

Figure 40: North America Diabetes Supplements Market, by Dosage Form, 2021–2031

Figure 41: North America Diabetes Supplements Market, by Distribution Channel, 2020 and 2031

Figure 42: North America Diabetes Supplements Market, by Distribution Channel, 2021–2031

Figure 43: Europe Diabetes Supplements Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 44: Europe Diabetes Supplement Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 45: Europe Diabetes Supplement Market Attractiveness Analysis, by Country/Sub-region, 2021–2031 

Figure 46: Europe Diabetes Supplements Market Value Share Analysis, by Type, 2020 and 2031

Figure 47: Europe Diabetes Supplements Market Attractiveness Analysis, by Type, 2021–2031

Figure 48: Europe Diabetes Supplements Market, by Disease Type, 2020 and 2031

Figure 49: Europe Diabetes Supplements Market, by Disease Type, 2021–2031

Figure 50: Europe Diabetes Supplements Market, by Dosage Form, 2020 and 2031

Figure 51: Europe Diabetes Supplements Market, by Dosage Form, 2021–2031

Figure 52: Europe Diabetes Supplements Market, by Distribution Channel, 2020 and 2031

Figure 53: Europe Diabetes Supplements Market, by Distribution Channel, 2021–2031

Figure 54: Asia Pacific Diabetes Supplements Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 55: Asia Pacific Diabetes Supplement Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 56: Asia Pacific Diabetes Supplement Market Attractiveness Analysis, by Country/Sub-region, 2021–2031 

Figure 57: Asia Pacific Diabetes Supplements Market Value Share Analysis, by Type, 2020 and 2031

Figure 58: Asia Pacific Diabetes Supplements Market Attractiveness Analysis, by Type, 2021–2031

Figure 59: Asia Pacific Diabetes Supplements Market, by Disease Type, 2020 and 2031

Figure 60: Asia Pacific Diabetes Supplements Market, by Disease Type, 2021–2031

Figure 61: Asia Pacific Diabetes Supplements Market, by Dosage Form, 2020 and 2031

Figure 62: Asia Pacific Diabetes Supplements Market, by Dosage Form, 2021–2031

Figure 63: Asia Pacific Diabetes Supplements Market, by Distribution Channel, 2020 and 2031

Figure 64: Asia Pacific Diabetes Supplements Market, by Distribution Channel, 2021–2031

Figure 65: Latin America Diabetes Supplements Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 66: Latin America Diabetes Supplement Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 67: Latin America Diabetes Supplement Market Attractiveness Analysis, by Country/Sub-region, 2021–2031 

Figure 68: Latin America Diabetes Supplements Market Value Share Analysis, by Type, 2020 and 2031

Figure 69: Latin America Diabetes Supplements Market Attractiveness Analysis, by Type, 2021–2031

Figure 70: Latin America Diabetes Supplements Market, by Disease Type, 2020 and 2031

Figure 71: Latin America Diabetes Supplements Market, by Disease Type, 2021–2031

Figure 72: Latin America Diabetes Supplements Market, by Dosage Form, 2020 and 2031

Figure 73: Latin America Diabetes Supplements Market, by Dosage Form, 2021–2031

Figure 74: Latin America Diabetes Supplements Market, by Distribution Channel, 2020 and 2031

Figure 75: Latin America Diabetes Supplements Market, by Distribution Channel, 2021–2031

Figure 76: Middle East & Africa Diabetes Supplements Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 77: Middle East & Africa Diabetes Supplement Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 78: Middle East & Africa Diabetes Supplement Market Attractiveness Analysis, by Country/Sub-region, 2021–2031 

Figure 79: Middle East & Africa Diabetes Supplements Market Value Share Analysis, by Type, 2020 and 2031

Figure 80: Middle East & Africa Diabetes Supplements Market Attractiveness Analysis, by Type, 2021–2031

Figure 81: Middle East & Africa Diabetes Supplements Market, by Disease Type, 2020 and 2031

Figure 82: Middle East & Africa Diabetes Supplements Market, by Disease Type, 2021–2031

Figure 83: Middle East & Africa Diabetes Supplements Market, by Dosage Form, 2020 and 2031

Figure 84: Middle East & Africa Diabetes Supplements Market, by Dosage Form, 2021–2031

Figure 85: Middle East & Africa Diabetes Supplements Market, by Distribution Channel, 2020 and 2031

Figure 86: Middle East & Africa Diabetes Supplements Market, by Distribution Channel, 2021–2031

Figure 87: Global Diabetes Supplements Market Share, by Company, 2020

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Diabetes Supplements Market